SCNI
Scinai Immunotherapeutics Ltd.

5,758
Mkt Cap
$673,900.00
Volume
14,890.00
52W High
$6.18
52W Low
$0.613
PE Ratio
-0.06
SCNI Fundamentals
Price
$0.7992
Prev Close
$0.79
Open
$0.79
50D MA
$0.9158
Beta
0.79
Avg. Volume
56,037.70
EPS (Annual)
$5.99
P/B
0.15
Rev/Employee
$21,326.55
$8.32
Loading...
Loading...
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
31

Frequently Asked Questions

What is Market Cap of Scinai Immunotherapeutics Ltd - ADR?
What is the 52-week high for Scinai Immunotherapeutics Ltd - ADR?
What is the 52-week low for Scinai Immunotherapeutics Ltd - ADR?
What is Scinai Immunotherapeutics Ltd - ADR stock price today?
What was Scinai Immunotherapeutics Ltd - ADR stock price yesterday?
What is the PE ratio of Scinai Immunotherapeutics Ltd - ADR?
What is the Price-to-Book ratio of Scinai Immunotherapeutics Ltd - ADR?
What is the 50-day moving average of Scinai Immunotherapeutics Ltd - ADR?
How many employees does Scinai Immunotherapeutics Ltd - ADR have?

Latest SCNI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.